疫苗佐劑市場規模、佔有率、趨勢分析報告：按類型、給藥方法、應用、地區、細分預測，2025-2030 年

Vaccine Adjuvants Market Size, Share & Trends Analysis Report By Type (Pathogen, Adjuvant Emulsion, Particulate), By Administration (Oral, Intradermal, Intranasal, Intramuscular), By Application, By Region, And Segment Forecasts, 2025 - 2030

出版日期: 2024年12月17日 | 出版商:

Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

疫苗佐劑市場的成長與趨勢

根據Grand View Research, Inc.的新報告，到2030年全球疫苗佐劑市場規模預計將達到48.6億美元。預計 2025 年至 2030 年間，市場複合年成長率為 4.32%。由於創新疫苗抗原的免疫抗原性較差，佐劑研究在疫苗研發中逐漸顯得重要。此外，人們越來越關注提供對現有和新出現的疾病的持久免疫力，預計將推動對疫苗佐劑的需求。

此外，子宮頸癌發生率的上升預計將促進市場的發展。根據 NCBI 統計，每年約有 15,000 名女性死於子宮頸癌。其他公司正在開發能夠長期增強免疫反應的佐劑，例如 GSK 的 AS04 佐劑（用於人類乳突病毒疫苗）。

疫苗佐劑市場報告重點

疫苗佐劑市場根據類型分為佐劑乳液、病原體、顆粒物、組合藥物和其他。 2024 年，粒狀物市場佔有率。
感染疾病部門在 2024 年佔據最大的收益佔有率，佔 68.0%。這一巨大比例是由於瘧疾、流感、甲型肝炎、乙型肝炎和丙型肝炎等感染疾病的流行逐漸增加。
給藥方式分為口服、皮內、鼻內、肌肉注射和其他。由於更好的免疫特異性，肌肉注射部分預計將在 2024 年佔據最大的收益佔有率，為 33.8%。
北美將主導市場，到 2024 年將佔據最大的收益佔有率，達到 39.4%。成長要素對新療法研發的投入增加以及致命傳染病的增加。

疫苗佐劑市場：關鍵要點
疫苗佐劑市場：2024 年和 2030 年趨勢和市場佔有率分析
病原體
- 2018 年至 2030 年病原體市場估計與預測
佐劑乳液
- 2018 年至 2030 年佐劑乳液市場估計與預測
微粒
- 2018 年至 2030 年細顆粒市場估計與預測
組合
- 2018 年至 2030 年綜合市場估計與預測
其他
- 2018 年至 2030 年其他市場估計與預測

第 5 章疫苗佐劑：依用途估計與趨勢分析

疫苗佐劑市場：關鍵要點
疫苗佐劑市場：2024 年和 2030 年趨勢和市場佔有率分析
感染疾病
- 2018 年至 2030 年感染疾病市場估計與預測
癌症
- 2018 年至 2030 年癌症市場估計與預測
其他
- 2018 年至 2030 年其他市場估計與預測

第 6 章疫苗佐劑：按給藥方法分類的估計和趨勢

疫苗佐劑市場：關鍵要點
疫苗佐劑市場：2024 年和 2030 年趨勢和市場佔有率分析
口服
- 2018 年至 2030 年口腔市場估計與預測
皮內
- 2018 年至 2030 年皮內注射市場估計與預測
鼻內
- 2018 年至 2030 年鼻腔給藥市場估計與預測
肌肉注射
- 2018 年至 2030 年肌肉注射市場估計與預測
其他
- 2018 年至 2030 年其他市場估計與預測

第 7 章疫苗佐劑市場：區域、估計與趨勢分析

區域展望
疫苗佐劑市場（按地區）: 關鍵要點
北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 丹麥
- 瑞典
- 挪威
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 泰國
- 韓國
拉丁美洲
- 巴西
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 科威特

第8章競爭格局

主要市場參與企業的近期趨勢及影響分析
市場參與企業分類
- GSK
- Novartis/CSL
- Agenus
- Adjuvance
- Novavax
- SPI Pharma
- Invivogen
- Avanti Polar Lipids
- Brentagg

簡介目錄圖表

Product Code: GVR-1-68038-612-7

Vaccine Adjuvants Market Growth & Trends:

The global vaccine adjuvants market is expected to reach USD 4.86 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 4.32% from 2025 to 2030. The significance of adjuvant research in the development of vaccines has increased gradually due to inadequate immunogenicity of innovative vaccine antigens. In addition, the growing focus on long-lasting immunization effect against existing and emerging diseases is expected to boost the demand for vaccine adjuvants.

Furthermore, rising prevalence of cervical cancer is anticipated to boost the market. According to NCBI, around 15,000 females die every year due to cervical cancer. There are certain companies developing vaccine adjuvants for this type of cancer in order to enhance the efficacy, such as AS04 adjuvant-adsorbed (human papillomavirus vaccine) by GSK, which boosts the immune response for a longer duration.

Vaccine Adjuvants Market Report Highlights:

The vaccine adjuvants market is segmented based on type into an adjuvant emulsion, pathogen, particulate, combination, and others. The particulate segment held the largest market share in 2024
The infectious diseases segment accounted for the largest revenue share of 68.0% in 2024. This large share can be attributed to the gradually growing prevalence of infectious diseases, such as malaria, influenza, hepatitis A, B, & C, and others.
The administration segment is categorized into oral, intradermal, intranasal, intramuscular, and others. Due to better immune specificity, the intramuscular segment accounted for the largest revenue share of 33.8% in 2024
North America dominated the market and accounted for the largest revenue share of 39.4% in 2024. The factors contributing to the growth of the market in the North American region are a rise in investments for R&D of new therapeutics and an increase in fatal epidemic diseases.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
- 1.1.1. Type
- 1.1.2. Application
- 1.1.3. Administration type
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
- 1.3.1. Purchased database.
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Application outlook
- 2.2.3. Administration outlook
- 2.2.4. Regional outlook
2.3. Competitive Insights

Chapter 3. Vaccine Adjuvants Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
3.4. Vaccine Adjuvants Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
  - 3.4.1.1. Supplier power
  - 3.4.1.2. Buyer power
  - 3.4.1.3. Substitution threat
  - 3.4.1.4. Threat of new entrant
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Technological landscape
  - 3.4.2.3. Economic landscape

Chapter 4. Vaccine Adjuvants: Type Estimates & Trend Analysis

4.1. Vaccine Adjuvants Market: Key Takeaways
4.2. Vaccine Adjuvants Market: Movement & Market Share Analysis, 2024 & 2030
4.3. Pathogen
- 4.3.1. Pathogen market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Adjuvant emulsion
- 4.4.1. Adjuvant emulsion market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Particulate
- 4.5.1. Particulate market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Combination
- 4.6.1. Combination market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Others
- 4.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Vaccine Adjuvants: Application Estimates & Trend Analysis

5.1. Vaccine Adjuvants Market: Key Takeaways
5.2. Vaccine Adjuvants Market: Movement & Market Share Analysis, 2024 & 2030
5.3. Infectious diseases
- 5.3.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Cancer
- 5.4.1. Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Others
- 5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Vaccine Adjuvants: Administration Estimates & Trend Analysis

6.1. Vaccine Adjuvants Market: Key Takeaways
6.2. Vaccine Adjuvants Market: Movement & Market Share Analysis, 2024 & 2030
6.3. Oral
- 6.3.1. Oral market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Intradermal
- 6.4.1. Intradermal market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Intranasal
- 6.5.1. Intranasal market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Intramuscular
- 6.6.1. Intramuscular market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Others
- 6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Vaccine Adjuvants Market: Regional Estimates & Trend Analysis

7.1. Regional Outlook
7.2. Vaccine Adjuvants Market by Region: Key Takeaways
7.3. North America
- 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.2. U.S.
  - 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.3. Canada
  - 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.4. Mexico
  - 7.3.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
- 7.4.1. UK
  - 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.2. Germany
  - 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.3. France
  - 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.4. Italy
  - 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.5. Spain
  - 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.6. Denmark
  - 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.7. Sweden
  - 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.8. Norway
  - 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
- 7.5.1. Japan
  - 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.2. China
  - 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.3. India
  - 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.4. Australia
  - 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.5. Thailand
  - 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.6. South Korea
  - 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
- 7.6.1. Brazil
  - 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.2. Argentina
  - 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
- 7.7.1. South Africa
  - 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.2. Saudi Arabia
  - 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.3. UAE
  - 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.4. Kuwait
  - 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
- 8.2.1. GSK
  - 8.2.1.1. Company overview
  - 8.2.1.2. Financial performance
  - 8.2.1.3. Product benchmarking
  - 8.2.1.4. Strategic initiatives
- 8.2.2. Novartis/CSL
  - 8.2.2.1. Company overview
  - 8.2.2.2. Financial performance
  - 8.2.2.3. Product benchmarking
  - 8.2.2.4. Strategic initiatives
- 8.2.3. Agenus
  - 8.2.3.1. Company overview
  - 8.2.3.2. Financial performance
  - 8.2.3.3. Product benchmarking
  - 8.2.3.4. Strategic initiatives
- 8.2.4. Adjuvance
  - 8.2.4.1. Company overview
  - 8.2.4.2. Financial performance
  - 8.2.4.3. Product benchmarking
  - 8.2.4.4. Strategic initiatives
- 8.2.5. Novavax
  - 8.2.5.1. Company overview
  - 8.2.5.2. Financial performance
  - 8.2.5.3. Product benchmarking
  - 8.2.5.4. Strategic initiatives
- 8.2.6. SPI Pharma
  - 8.2.6.1. Company overview
  - 8.2.6.2. Financial performance
  - 8.2.6.3. Product benchmarking
  - 8.2.6.4. Strategic initiatives
- 8.2.7. Invivogen
  - 8.2.7.1. Company overview
  - 8.2.7.2. Financial performance
  - 8.2.7.3. Product benchmarking
  - 8.2.7.4. Strategic initiatives
- 8.2.8. Avanti Polar Lipids
  - 8.2.8.1. Company overview
  - 8.2.8.2. Financial performance
  - 8.2.8.3. Product benchmarking
  - 8.2.8.4. Strategic initiatives
- 8.2.9. Brentagg
  - 8.2.9.1. Company overview
  - 8.2.9.2. Financial performance
  - 8.2.9.3. Product benchmarking
  - 8.2.9.4. Strategic initiatives

簡介目錄圖表

List of Tables

Table 1 List of Abbreviation
Table 2 North America Vaccine Adjuvants market, by type, 2018 - 2030 (USD Million)
Table 3 North America vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 4 North America vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 5 North America vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 7 U.S. vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 8 U.S. vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 9 Canada vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 10 Canada vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 11 Canada vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 12 Mexico vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 13 Mexico vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 14 Mexico vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 15 Europe vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 16 Europe vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 17 Europe vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 18 Europe vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
Table 19 Germany vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 20 Germany vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 21 Germany vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 22 UK vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 23 UK vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 24 UK vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 25 France vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 26 France vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 27 France vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 28 Italy vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 29 Italy vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 30 Italy vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 31 Spain vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 32 Spain vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 33 Spain vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 34 Denmark vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 35 Denmark vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 36 Denmark vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 37 Sweden vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 38 Sweden vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 39 Sweden vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 40 Norway vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 41 Norway vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 42 Norway vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 43 Asia Pacific vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 44 Asia Pacific vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 45 Asia Pacific vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 46 Asia Pacific vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
Table 47 Japan vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 48 Japan vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 49 Japan vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 50 China vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 51 China vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 52 China vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 53 India vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 54 India vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 55 India vaccine adjuvants market, by administration, (USD Million) 2018 - 2030
Table 56 Australia vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 57 Australia vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 58 Australia vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 59 Thailand vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 60 Thailand vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 61 Thailand vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 62 South Korea vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 63 South Korea vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 64 South Korea vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 65 Latin America vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 66 Latin America vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 67 Latin America vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 68 Latin America vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
Table 69 Brazil vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 70 Brazil vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 71 Brazil vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 72 Argentina vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 73 Argentina vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 74 Argentina vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa vaccine adjuvants market, by region, 2018 - 2030 (USD Million)
Table 79 South Africa vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 80 South Africa vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 81 South Africa vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 85 UAE vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 86 UAE vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 87 UAE vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)
Table 88 Kuwait vaccine adjuvants market, by type, 2018 - 2030 (USD Million)
Table 89 Kuwait vaccine adjuvants market, by application, 2018 - 2030 (USD Million)
Table 90 Kuwait vaccine adjuvants market, by administration, 2018 - 2030 (USD Million)